The Assistance Fund will pay $4 million to resolve claims that the Florida-based charity acted as a conduit for companies including Biogen Inc. and Novartis AG to pay kickbacks to Medicare patients using their high-priced multiple sclerosis drugs, the U.S. Justice Department said.
A trio of polls showed a majority of Americans support Medicare for All, but offered conflicting signals about whether the proposed healthcare overhaul could hurt the party in the November 2020 general election.
Perhaps no issue has divided the field of Democratic 2020 presidential hopefuls more than the debate over “Medicare for All.”
Oooooh, That’s Scary! Welcome to the Dark Side of Biopharma
Bankruptcy, Biotech, Bioterrorism, Births, Business, Carcinogens, China, CRISPR, Fraud, Gene Editing, Genes, Government, HIV, Medicare, N-nitrosodimethylamine (NDMA), Opioids, Pharma, PhRMA, Restructuring, Spinal Muscular Atrophy (SMA), StudiesFor Halloween, BioSpace collected six tales of thrills and chills from the pharma and biotech industries that will surely have you covering your eyes in terror.
About a quarter of the dollars spent on healthcare in the United States may be wasted, a new analysis suggests.
U.S. President Donald Trump will unveil an executive order aimed at strengthening Medicare for seniors, seeking to improve the health program’s fiscal position and offer more affordable plan options, administration officials said.
U.S. House Speaker Nancy Pelosi released proposed legislation that would allow the federal government to negotiate the prices of hundreds of prescription drugs for Medicare healthcare beneficiaries as well as other consumers.
Pharma stock prices took an across-the-board tumble after Speaker of the House Nancy Pelosi unveiled a working plan to lower the prices of 250 of the most expensive drugs covered by Medicare and other government-funded programs.
Democratic presidential candidates disagree on the best path forward for health insurance coverage.
The owner of a telemarketing company implicated in the largest component of a $1.2 billion Medicare fraud involving the supply of medically unnecessary orthotic braces pleaded guilty to criminal charges, the U.S. Department of Justice said.
